chlorothiazide sodium
Chlorothiazide Sodium for Injection, USP(For Intravenous Use)
Approved
Approval ID
377dc515-e381-4196-8bc7-b738606c57ac
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 14, 2021
Manufacturers
FDA
Sagent Pharmaceuticals
DUNS: 796852890
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
chlorothiazide sodium
PRODUCT DETAILS
NDC Product Code25021-305
Application NumberANDA202462
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateNovember 16, 2020
Generic Namechlorothiazide sodium
INGREDIENTS (3)
mannitolInactive
Code: 3OWL53L36A
Classification: IACT
sodium hydroxideInactive
Code: 55X04QC32I
Classification: IACT
chlorothiazide sodiumActive
Quantity: 500 mg in 18 mL
Code: SN86FG7N2K
Classification: ACTIM